The Drug Enforcement Administration (DEA) has granted narcotic treatment programs (NTPs) an exception to 21 CFR 1301.74(i) in order to provide consistent dosing to patients enrolled.
Nora Volkow, M.D., Director of the National Institute on Drug Abuse (NIDA), highlights the added risks that populations with substance use disorder face during the COVID-19 pandemic.
Expert advisory meeting convened by FORE to discuss pain management and consider barriers to implementing or changing pain management practices.
Expert advisory meeting convened by FORE to consider the healthcare delivery system and payment model changes that are needed to facilitate access to treatment.
Expert advisory meeting convened by FORE to explore opportunities in medical education and training related to preventing, screening, and treating opioid use disorder.
Expert advisory meeting convened by FORE to highlight barriers and address challenges that patients with opioid use disorder face in accessing appropriate treatment.